← Back to Conditions

Oculopharyngeal muscular dystrophy

disorder
SNOMED 77097004CUI C0270952

Overview

Source: MedlinePlus.gov, National Library of Medicine. Not a substitute for medical advice.

Research Evidence

Peer-reviewed studies linked via MeSH term "Muscular Dystrophy, Oculopharyngeal" from the MEDLINE/PubMed database.

Sort:
A systematic review and meta-analysis of measurements of tongue and hand strength and endurance using the Iowa Oral Performance Instrument (IOPI).
[object Object], [object Object], [object Object] et al. · Dysphagia · 2013
PMID: 23468283Meta-Analysis
Speech pathology interventions in patients with neuromuscular diseases: a systematic review.
[object Object], [object Object], [object Object] et al. · Folia Phoniatr Logop · 2011
PMID: 20689305Meta-Analysis
Emerging and established biomarkers of oculopharyngeal muscular dystrophy.
[object Object], [object Object], [object Object] et al. · Neuromuscul Disord · 2023
PMID: 37926637Review
Eyelid ptosis (Blepharoptosis) for the primary care practitioner.
[object Object], [object Object] · Dis Mon · 2020
PMID: 32605719Review
Severe Ocular Complications After Blepharoptosis Correction in the Oculopharyngeal Muscular Dystrophy Patient: Literature Review and Case Presentation.
[object Object], [object Object], [object Object] et al. · Ann Plast Surg · 2020
PMID: 31833892Review
Gastrointestinal Dysmotility in MNGIE: from thymidine phosphorylase enzyme deficiency to altered interstitial cells of Cajal.
[object Object], [object Object], [object Object] · Orphanet J Rare Dis · 2019
PMID: 30736844ReviewFull text (PMC)
Genetic neuromuscular disorders: living the era of a therapeutic revolution. Part 1: peripheral neuropathies.
[object Object], [object Object], [object Object] et al. · Neurol Sci · 2019
PMID: 30847674Review
Peripheral neuropathy and gastroenterologic disorders: an overview on an underrecognized association.
[object Object], [object Object], [object Object] et al. · Acta Biomed · 2018
PMID: 30561392ReviewFull text (PMC)
Recent advances in liver transplantation for metabolic disease.
[object Object] · J Inherit Metab Dis · 2017
PMID: 28168361Review
Progress on gene therapy, cell therapy, and pharmacological strategies toward the treatment of oculopharyngeal muscular dystrophy.
[object Object], [object Object], [object Object] et al. · Hum Gene Ther · 2015
PMID: 25860803Review

Signs & Symptoms

Based on Human Phenotype Ontology (HPO) disease-phenotype annotations.

Gait disturbance
Always present (100%)HP:0001288
Nasal speech
Always present (100%)HP:0001611
Progressive ptosis
Always present (100%)HP:0007838
Proximal limb muscle weakness
Always present (100%)HP:0003701
Abnormal skeletal muscle fibre morphology
Very frequent (80-99%)HP:0004303
Deglutition disorder
Very frequent (80-99%)HP:0002015
Eye muscle paralysis
Very frequent (80-99%)HP:0000602
Eyelid ptosis
Very frequent (80-99%)HP:0000508
Myopathy
Very frequent (80-99%)HP:0003198
Ragged-red muscle fibers
Very frequent (80-99%)HP:0003200
Rimmed vacuoles
Very frequent (80-99%)HP:0003805
Spondylolisthesis
Very frequent (80-99%)HP:0003302
Tiredness
Very frequent (80-99%)HP:0012378
Angulated muscle fibers
Frequent (30-79%)HP:0034045
Axial muscle weakness
Frequent (30-79%)HP:0003327
Dysphonia
Frequent (30-79%)HP:0001618
Fatty replacement of skeletal muscle
Frequent (30-79%)HP:0012548
Feeding difficulties
Frequent (30-79%)HP:0011968
Limb-girdle muscle weakness
Frequent (30-79%)HP:0003325
Muscle fibre intranuclear inclusion bodies
Frequent (30-79%)HP:0100304
Pain
Frequent (30-79%)HP:0012531
Reduced FEV1
Frequent (30-79%)HP:0032342
Tongue muscle weakness
Frequent (30-79%)HP:0000183
Wasting of the tongue
Frequent (30-79%)HP:0012473
Weakness of face
Frequent (30-79%)HP:0030319
Wet voice
Frequent (30-79%)HP:6001011
Elevated serum creatine phosphokinase
Occasional (5-29%)HP:0003236
Mask-like facies
Occasional (5-29%)HP:0000298
Intellectual impairment
Very rare (1-4%)HP:0100543
Sleep apnea
Very rare (1-4%)HP:0010535

Quick Facts

SNOMED CT
77097004
UMLS CUI
C0270952
Fully Specified Name
Oculopharyngeal muscular dystrophy (disorder)
Specialists
0
Diagnostic Biomarkers
0
HPO Phenotypes
30
Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.